Clinical Application of exhaled Nitric Oxide measurements in PrimarY care

Assessing the utility of exhaled nitric oxide measurements in the diagnosis of asthma and the monitoring of inhaled steroid treatment in primary care

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000354684

Acronym

CANOPY

Enrollment

200

Registered

2005-09-09

Start date

2005-01-05

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Algorithms based on previous research are used to guide diagnostic and treatment decision making in patients with asthma in primary care. Patients will be followed up at 3 month intervals for one year using the algorithm to guide clinical decisions making regarding inhaled steroid dose.

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Diagnosis

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

12 Years to No maximum

Healthy volunteers

Inclusion criteria

Diagnostic arm: Inclusion - patients over 12yrs old with wheeze, cough or dyspnoea for >6weeks duration. Treatment arm: Inclusion - asthmatic patients >12yrs old.

Exclusion criteria

Exclusion for both arms current or recent ex-smokers (<6months).

Outcome results